Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test

A P Gjesing; L L Kjems; M A Vestmar; N Grarup; A Linneberg; C F Deacon; J J Holst; O Pedersen; Torben Hansen

doi:10.1007/s00125-010-1940-4

Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test

A P Gjesing, L L Kjems, M A Vestmar, N Grarup, A Linneberg, C F Deacon, J J Holst, O Pedersen, Torben Hansen

20 Citations (Scopus)

Abstract

Aims/hypothesis: The transcription factor 7-like 2 (TCF7L2) rs7903146 T allele associates with type 2 diabetes in several populations, possibly mediated via decreased incretin secretion and/or action and altered beta and alpha cell function. We aimed to study circulating levels of glucose, proinsulin, insulin, C-peptide, glucagon, glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2) and gastric inhibitory polypeptide (GIP) among individuals carrying the high-risk rs7903146 TT genotype and lowrisk CC genotype following a meal test. Methods: A meal challenge was performed in 31 glucose-tolerant men (age 54±7 years and BMI 26±3 kg/m²) with rs7903146 TT genotype and 31 glucose-tolerant age- and BMI-matched men with CC genotype (age 53±6 years and BMI 26±3 kg/m2). Serum proinsulin, insulin, C-peptide and plasma glucose, glucagon, GLP-1, GLP-2 and GIP were obtained 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 180, 210, and 240 min after ingestion of a standardised breakfast meal. Results: An elevated incremental AUC for plasma glucose was observed among TT genotype carriers (CC carriers 21.8±101.9 mmol/lxmin vs TT carriers 97.9±89.2 mmol/ lxmin, p=0.001). TT carriers also had increased AUCs for proinsulin (CC carriers 6,030±3,001 pmol/lxmin vs TT carriers 6,917±4,820 pmol/lxmin, p=0.03), C-peptide (CC carriers 397.6±131.9 nmol/lxmin vs TT carriers 417.1± 109.3 nmol/lxmin, p=0.04) and GIP (CC carriers 12,310± 3,840 pmol/lxmin vs TT carriers 14,590±5,910 pmol/lx min, p=0.004). Conclusions/interpretation: Middle-aged normoglycaemic individuals carrying the rs7903146 TCF7L2 risk TT genotype show early signs of dysregulated glucose metabolism, decreased processing of proinsulin and elevated GIP secretion following a meal challenge.

Original language	English
Journal	Diabetologia
Volume	54
Issue number	1
Pages (from-to)	103-10
Number of pages	8
ISSN	0012-186X
DOIs	https://doi.org/10.1007/s00125-010-1940-4
Publication status	Published - 1 Jan 2011

Keywords

Alleles
Blood Glucose
Gastric Inhibitory Polypeptide
Genetic Predisposition to Disease
Genotype
Humans
Male
Middle Aged
Proinsulin
Transcription Factor 7-Like 2 Protein

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-010-1940-4

Cite this

Gjesing, A. P., Kjems, L. L., Vestmar, M. A., Grarup, N., Linneberg, A., Deacon, C. F., Holst, J. J., Pedersen, O., & Hansen, T. (2011). Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test. Diabetologia, 54(1), 103-10. https://doi.org/10.1007/s00125-010-1940-4

Gjesing, AP, Kjems, LL, Vestmar, MA , Grarup, N , Linneberg, A , Deacon, CF , Holst, JJ , Pedersen, O & Hansen, T 2011, 'Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test', Diabetologia, vol. 54, no. 1, pp. 103-10. https://doi.org/10.1007/s00125-010-1940-4

@article{8dad8713e4894a3d99939879885f7c84,

title = "Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test",

abstract = "Aims/hypothesis: The transcription factor 7-like 2 (TCF7L2) rs7903146 T allele associates with type 2 diabetes in several populations, possibly mediated via decreased incretin secretion and/or action and altered beta and alpha cell function. We aimed to study circulating levels of glucose, proinsulin, insulin, C-peptide, glucagon, glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2) and gastric inhibitory polypeptide (GIP) among individuals carrying the high-risk rs7903146 TT genotype and lowrisk CC genotype following a meal test. Methods: A meal challenge was performed in 31 glucose-tolerant men (age 54±7 years and BMI 26±3 kg/m2) with rs7903146 TT genotype and 31 glucose-tolerant age- and BMI-matched men with CC genotype (age 53±6 years and BMI 26±3 kg/m2). Serum proinsulin, insulin, C-peptide and plasma glucose, glucagon, GLP-1, GLP-2 and GIP were obtained 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 180, 210, and 240 min after ingestion of a standardised breakfast meal. Results: An elevated incremental AUC for plasma glucose was observed among TT genotype carriers (CC carriers 21.8±101.9 mmol/lxmin vs TT carriers 97.9±89.2 mmol/ lxmin, p=0.001). TT carriers also had increased AUCs for proinsulin (CC carriers 6,030±3,001 pmol/lxmin vs TT carriers 6,917±4,820 pmol/lxmin, p=0.03), C-peptide (CC carriers 397.6±131.9 nmol/lxmin vs TT carriers 417.1± 109.3 nmol/lxmin, p=0.04) and GIP (CC carriers 12,310± 3,840 pmol/lxmin vs TT carriers 14,590±5,910 pmol/lx min, p=0.004). Conclusions/interpretation: Middle-aged normoglycaemic individuals carrying the rs7903146 TCF7L2 risk TT genotype show early signs of dysregulated glucose metabolism, decreased processing of proinsulin and elevated GIP secretion following a meal challenge.",

keywords = "Alleles, Blood Glucose, Gastric Inhibitory Polypeptide, Genetic Predisposition to Disease, Genotype, Humans, Male, Middle Aged, Proinsulin, Transcription Factor 7-Like 2 Protein",

author = "Gjesing, {A P} and Kjems, {L L} and Vestmar, {M A} and N Grarup and A Linneberg and Deacon, {C F} and Holst, {J J} and O Pedersen and Torben Hansen",

year = "2011",

month = jan,

day = "1",

doi = "10.1007/s00125-010-1940-4",

language = "English",

volume = "54",

pages = "103--10",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test

AU - Gjesing, A P

AU - Kjems, L L

AU - Vestmar, M A

AU - Grarup, N

AU - Linneberg, A

AU - Deacon, C F

AU - Holst, J J

AU - Pedersen, O

AU - Hansen, Torben

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Aims/hypothesis: The transcription factor 7-like 2 (TCF7L2) rs7903146 T allele associates with type 2 diabetes in several populations, possibly mediated via decreased incretin secretion and/or action and altered beta and alpha cell function. We aimed to study circulating levels of glucose, proinsulin, insulin, C-peptide, glucagon, glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2) and gastric inhibitory polypeptide (GIP) among individuals carrying the high-risk rs7903146 TT genotype and lowrisk CC genotype following a meal test. Methods: A meal challenge was performed in 31 glucose-tolerant men (age 54±7 years and BMI 26±3 kg/m2) with rs7903146 TT genotype and 31 glucose-tolerant age- and BMI-matched men with CC genotype (age 53±6 years and BMI 26±3 kg/m2). Serum proinsulin, insulin, C-peptide and plasma glucose, glucagon, GLP-1, GLP-2 and GIP were obtained 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 180, 210, and 240 min after ingestion of a standardised breakfast meal. Results: An elevated incremental AUC for plasma glucose was observed among TT genotype carriers (CC carriers 21.8±101.9 mmol/lxmin vs TT carriers 97.9±89.2 mmol/ lxmin, p=0.001). TT carriers also had increased AUCs for proinsulin (CC carriers 6,030±3,001 pmol/lxmin vs TT carriers 6,917±4,820 pmol/lxmin, p=0.03), C-peptide (CC carriers 397.6±131.9 nmol/lxmin vs TT carriers 417.1± 109.3 nmol/lxmin, p=0.04) and GIP (CC carriers 12,310± 3,840 pmol/lxmin vs TT carriers 14,590±5,910 pmol/lx min, p=0.004). Conclusions/interpretation: Middle-aged normoglycaemic individuals carrying the rs7903146 TCF7L2 risk TT genotype show early signs of dysregulated glucose metabolism, decreased processing of proinsulin and elevated GIP secretion following a meal challenge.

AB - Aims/hypothesis: The transcription factor 7-like 2 (TCF7L2) rs7903146 T allele associates with type 2 diabetes in several populations, possibly mediated via decreased incretin secretion and/or action and altered beta and alpha cell function. We aimed to study circulating levels of glucose, proinsulin, insulin, C-peptide, glucagon, glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2) and gastric inhibitory polypeptide (GIP) among individuals carrying the high-risk rs7903146 TT genotype and lowrisk CC genotype following a meal test. Methods: A meal challenge was performed in 31 glucose-tolerant men (age 54±7 years and BMI 26±3 kg/m2) with rs7903146 TT genotype and 31 glucose-tolerant age- and BMI-matched men with CC genotype (age 53±6 years and BMI 26±3 kg/m2). Serum proinsulin, insulin, C-peptide and plasma glucose, glucagon, GLP-1, GLP-2 and GIP were obtained 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 180, 210, and 240 min after ingestion of a standardised breakfast meal. Results: An elevated incremental AUC for plasma glucose was observed among TT genotype carriers (CC carriers 21.8±101.9 mmol/lxmin vs TT carriers 97.9±89.2 mmol/ lxmin, p=0.001). TT carriers also had increased AUCs for proinsulin (CC carriers 6,030±3,001 pmol/lxmin vs TT carriers 6,917±4,820 pmol/lxmin, p=0.03), C-peptide (CC carriers 397.6±131.9 nmol/lxmin vs TT carriers 417.1± 109.3 nmol/lxmin, p=0.04) and GIP (CC carriers 12,310± 3,840 pmol/lxmin vs TT carriers 14,590±5,910 pmol/lx min, p=0.004). Conclusions/interpretation: Middle-aged normoglycaemic individuals carrying the rs7903146 TCF7L2 risk TT genotype show early signs of dysregulated glucose metabolism, decreased processing of proinsulin and elevated GIP secretion following a meal challenge.

KW - Alleles

KW - Blood Glucose

KW - Gastric Inhibitory Polypeptide

KW - Genetic Predisposition to Disease

KW - Genotype

KW - Humans

KW - Male

KW - Middle Aged

KW - Proinsulin

KW - Transcription Factor 7-Like 2 Protein

U2 - 10.1007/s00125-010-1940-4

DO - 10.1007/s00125-010-1940-4

M3 - Journal article

C2 - 20957343

SN - 0012-186X

VL - 54

SP - 103

EP - 110

JO - Diabetologia

JF - Diabetologia

IS - 1

ER -

Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this